Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €152.24 million as of April 29, 2025. Its market cap has increased by 5.66% in one year.

Market Cap

152.24M

Enterprise Value

192.86M

Revenue

51.39M

Ranking

n/a

PE Ratio

9.61

Stock Price

€7.53

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 152.24M, a decrease of -21.59%. That is a compound annual growth rate of -1.31%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2025	150.89M	-18.46%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	285.46B
Siemens Aktiengesellschaft	161.69B
Deutsche Telekom AG	152.29B
Allianz SE	138.21B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	78.73B
Rheinmetall AG	60.23B
Siemens Energy AG	53.67B
Merck KGaA	52.67B

Market Cap Rankings